+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Digital Diabetes Management Market - Global Forecast 2026-2032- Product Image
Digital Diabetes Management Market - Global Forecast 2026-2032- Product Image
Sale

Digital Diabetes Management Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5292896
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Digital Diabetes Management Market is projected to reach USD 27.25 Billion in 2026. It is expected to continue growing at a CAGR of 19.71%, reaching USD 79.86 Billion by 2032.

Digital diabetes management is becoming a core layer of chronic disease care, combining continuous glucose monitoring, connected blood glucose meters, insulin pumps, smart insulin pens, mobile apps, telehealth, coaching, and analytics platforms. These technologies support real-time glucose visibility, medication adherence, lifestyle tracking, remote clinical review, and personalized self-management for people living with type 1, type 2, and gestational diabetes.

Demand is supported by a measurable global disease burden. The International Diabetes Federation estimated 537 million adults living with diabetes in 2021, with projections reaching 643 million by 2030 and 783 million by 2045. The World Health Organization also identifies diabetes as a major cause of blindness, kidney failure, heart attacks, stroke, and lower-limb amputation, making scalable, data-enabled diabetes care a strategic priority for providers, payers, employers, device manufacturers, and digital health stakeholders.

Transformative Shifts in the Digital Diabetes Landscape

The digital diabetes management landscape is shifting from episodic, clinic-centered care toward continuous, patient-centered diabetes management. Connected devices now generate real-time glucose, medication, activity, nutrition, and behavioral data, enabling earlier intervention, more personalized care pathways, and stronger support between clinical visits.

Reimbursement expansion, remote patient monitoring programs, value-based care models, and consumer adoption of wearables are accelerating this transformation. At the same time, interoperability requirements, cybersecurity expectations, clinical evidence standards, and evolving medical device regulations are raising the bar for vendors seeking durable clinical, regulatory, and commercial adoption.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is reshaping digital diabetes management through predictive glucose alerts, insulin dose decision support, automated pattern recognition, food and activity insights, and risk stratification. AI-enabled platforms can help identify hypoglycemia risk, hyperglycemia patterns, medication nonadherence, lifestyle triggers, and patients who may benefit from clinical outreach or therapy adjustment.

The cumulative impact is strongest when AI is combined with validated devices, clinician oversight, transparent model design, and explainable workflows. Because diabetes care involves safety-critical decisions, industry leaders must prioritize algorithm validation, bias monitoring, data privacy, cybersecurity, post-market performance monitoring, and regulatory alignment before scaling autonomous or semi-autonomous capabilities.

Key Regional Insights

Asia-Pacific represents one of the most important long-term digital diabetes management regions because China and India account for substantial diabetes populations and are scaling mobile-first healthcare models, connected monitoring, and chronic disease platforms. North America remains a leading adoption environment, supported by connected device penetration, remote patient monitoring reimbursement, telehealth normalization, and active regulatory oversight of software-enabled medical tools. Latin America, led by Brazil and Mexico, is expanding digital diabetes access as health systems respond to urbanization, obesity, cardiometabolic risk, and specialist shortages.

Europe benefits from structured diabetes care, public health system engagement, GDPR-driven data governance, and stronger evaluation standards for digital therapeutics and connected medical devices. The Middle East is advancing smart hospital, national digital health, and prevention programs, especially across GCC markets where diabetes and obesity are major policy priorities. Africa is earlier in adoption but offers meaningful potential through mobile health, community care, pharmacy networks, and lower-cost connected monitoring models that can extend diabetes support beyond specialist clinics.

Key Group Insights

ASEAN markets are increasingly relevant for mobile-enabled diabetes education, remote monitoring, pharmacy-led engagement, and primary care support as smartphone access expands and governments strengthen noncommunicable disease programs. GCC countries are investing in digital health infrastructure, specialty care capacity, obesity prevention, and national diabetes initiatives to address high cardiometabolic risk. The European Union provides a structured environment for evidence-based adoption through medical device regulation, data protection rules, interoperability policy, and cross-border digital health initiatives.

BRICS economies combine large diabetes populations with diverse reimbursement maturity, creating opportunities for scalable, localized, multilingual, and lower-cost digital diabetes platforms. G7 markets remain central for clinical validation, premium connected devices, reimbursement innovation, and integration with mature health systems. NATO members add a strategic focus on cyber resilience, secure health data exchange, emergency preparedness, and continuity of care across critical healthcare infrastructure.

Key Country Insights

The United States is a primary digital diabetes management adoption market, with the CDC reporting 38.4 million people with diabetes in 2021 and strong uptake of continuous glucose monitoring, remote monitoring, telehealth, and employer-sponsored digital care. Canada benefits from provincial diabetes programs and connected care initiatives, while Mexico and Brazil face rising prevalence and access gaps that favor affordable connected monitoring, mobile education, and pharmacy-enabled care. The United Kingdom leverages NHS pathways and national guidance for diabetes technology, while Germany, France, Italy, and Spain emphasize regulated, evidence-based adoption within public health systems and established chronic care frameworks.

Russia remains shaped by regional access variation, local procurement dynamics, and uneven digital health infrastructure. China and India offer major scale through mobile health ecosystems, expanding chronic care infrastructure, and large populations requiring earlier diagnosis and ongoing monitoring. Japan, Australia, and South Korea show strong readiness for connected devices, aging-population care models, digitally supported self-management, and integration of diabetes technology into broader preventive health and remote care strategies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated digital diabetes solutions that demonstrate improvements in HbA1c, time in range, hypoglycemia reduction, medication adherence, acute event prevention, patient engagement, and total cost of care. Interoperability with electronic health records, continuous glucose monitoring systems, insulin delivery devices, pharmacy systems, telehealth platforms, and payer workflows should be designed as a core product requirement rather than an afterthought.

Organizations should also strengthen AI governance, cybersecurity, health equity, accessibility, and localization strategies. Winning models will combine patient engagement, clinician workflow efficiency, reimbursement evidence, multilingual support, data protection compliance, and partnerships with health systems, payers, employers, pharmacies, and device manufacturers to deliver measurable outcomes across diverse care settings.

Research Methodology

This executive summary is developed through a structured secondary research approach using publicly available and recognized sources, including the International Diabetes Federation, World Health Organization, CDC, FDA, OECD, national health agencies, regulatory bodies, and peer-reviewed clinical literature. The analysis focuses on verified indicators relevant to digital diabetes management, including disease burden, technology adoption, care delivery models, reimbursement policies, and regulatory direction.

Insights are triangulated across diabetes prevalence, connected device adoption, telehealth implementation, remote patient monitoring use cases, data governance requirements, and digital health deployment patterns. Market interpretation emphasizes verified evidence, regional comparability, and practical implications for stakeholders operating across devices, software, analytics, telehealth, coaching, pharmacy care, and chronic disease management services.

Conclusion

Digital diabetes management is moving from optional support technology to an essential component of chronic disease infrastructure. Rising diabetes prevalence, expanding continuous glucose monitoring adoption, telehealth normalization, connected insulin delivery, and AI-enabled analytics are creating a more connected, proactive, and personalized model of diabetes care.

The strongest opportunities will emerge where clinical evidence, regulatory trust, reimbursement readiness, interoperability, cybersecurity, and patient-centered design align. Organizations that deliver secure, equitable, accessible, and measurable solutions will be best positioned to support the next phase of digital diabetes care across health systems, payers, employers, clinicians, and patients.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Digital Diabetes Management Market, by Product Type
7.1. Introduction
7.2. Glucose Monitoring Devices
7.2.1. Continuous Glucose Monitors
7.2.2. Self-Monitoring Blood Glucose Meters
7.3. Insulin Pumps
7.3.1. Automated Insulin Delivery Systems
7.3.2. Traditional Insulin Pumps
7.4. Mobile Apps
7.4.1. Activity Tracking Apps
7.4.2. Diet Management Apps
7.4.3. Sugar Tracking Apps
7.5. Software Solutions
7.5.1. Clinical Decision Support Systems
7.5.1.1. EMR Integrated Systems
7.5.1.2. Standalone Platforms
7.5.2. Data Management Software
7.6. Telehealth Services
7.6.1. Remote Monitoring Services
7.6.2. Virtual Consultations
8. Digital Diabetes Management Market, by Delivery Method
8.1. Introduction
8.2. Implantable Devices
8.2.1. Implantable Pumps
8.2.2. Integrated CGM Sensors
8.3. Invasive Devices
8.4. Non Invasive Devices
8.5. Wearable Devices
8.5.1. Smart Patches
8.5.2. Smartwatches
9. Digital Diabetes Management Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Home Care
9.4. Hospitals
9.5. Patients
10. Digital Diabetes Management Market, by Application
10.1. Introduction
10.2. Gestational Diabetes
10.3. Type 1 Diabetes
10.4. Type 2 Diabetes
11. Digital Diabetes Management Market, by Sales Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Digital Diabetes Management Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Digital Diabetes Management Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Digital Diabetes Management Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Afon Technology Ltd
16.3. AgaMatrix Inc
16.4. Ascensia Diabetes Care Holdings AG
16.5. B Braun Melsungen AG
16.6. Beta Bionics Inc
16.7. Biolinq Inc
16.8. DarioHealth Corp
16.9. Dexcom Inc
16.10. Diabeloop SA
16.11. Eli Lilly and Company
16.12. Embecta Corp
16.13. F Hoffmann La Roche Ltd
16.14. Glooko Inc
16.15. Insulet Corporation
16.16. LifeScan Inc
16.17. Medtronic plc
16.18. Medtrum Technologies Inc
16.19. MicroPort Scientific Corporation
16.20. Modular Medical Inc
16.21. One Drop
16.22. Senseonics Holdings Inc
16.23. Signos Inc
16.24. Tandem Diabetes Care Inc
16.25. Terumo Corporation
16.26. Virta Health Corp
16.27. Ypsomed Holding AG
17. Key Experts
List of Figures
FIGURE 1. Global Digital Diabetes Management Market, Years Considered for the Study
FIGURE 2. Global Digital Diabetes Management Market, Research Design
FIGURE 3. Global Digital Diabetes Management Market, Research Framework
FIGURE 4. Global Digital Diabetes Management Market, Data Triangulation
FIGURE 5. Global Digital Diabetes Management Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Digital Diabetes Management Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Digital Diabetes Management Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Digital Diabetes Management Market Size, by Delivery Method, 2025 vs 2032 (%)
FIGURE 9. Global Digital Diabetes Management Market Size, by Delivery Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Digital Diabetes Management Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Digital Diabetes Management Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Digital Diabetes Management Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Digital Diabetes Management Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Digital Diabetes Management Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 15. Global Digital Diabetes Management Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Digital Diabetes Management Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Digital Diabetes Management Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Digital Diabetes Management Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Digital Diabetes Management Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Digital Diabetes Management Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Digital Diabetes Management Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Digital Diabetes Management Market Segmentation & Coverage
TABLE 2. Global Digital Diabetes Management Market Size, 2017-2032 (USD Million)
TABLE 3. Global Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Glucose Monitoring Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Glucose Monitoring Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Glucose Monitoring Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Continuous Glucose Monitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Continuous Glucose Monitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Continuous Glucose Monitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Self-Monitoring Blood Glucose Meters Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Self-Monitoring Blood Glucose Meters Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Self-Monitoring Blood Glucose Meters Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Insulin Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Insulin Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Insulin Pumps Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Automated Insulin Delivery Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Automated Insulin Delivery Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Automated Insulin Delivery Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Traditional Insulin Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Traditional Insulin Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Traditional Insulin Pumps Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Mobile Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Mobile Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Mobile Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Activity Tracking Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Activity Tracking Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Activity Tracking Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Diet Management Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Diet Management Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Diet Management Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Sugar Tracking Apps Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Sugar Tracking Apps Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Sugar Tracking Apps Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Software Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Software Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Software Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Clinical Decision Support Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Clinical Decision Support Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Clinical Decision Support Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global EMR Integrated Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global EMR Integrated Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global EMR Integrated Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Standalone Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Standalone Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Standalone Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Data Management Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Data Management Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Data Management Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Telehealth Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Telehealth Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Telehealth Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Remote Monitoring Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Remote Monitoring Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Remote Monitoring Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Virtual Consultations Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Virtual Consultations Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Virtual Consultations Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 59. Global Implantable Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Implantable Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Implantable Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Implantable Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Implantable Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Implantable Pumps Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Integrated CGM Sensors Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Integrated CGM Sensors Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Integrated CGM Sensors Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Invasive Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Invasive Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Invasive Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Non Invasive Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Non Invasive Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Non Invasive Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Wearable Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Wearable Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Wearable Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Smart Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Smart Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Smart Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Smartwatches Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Smartwatches Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Smartwatches Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Patients Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Patients Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Patients Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Global Gestational Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Gestational Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Gestational Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Type 1 Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Type 1 Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Type 1 Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Type 2 Diabetes Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Type 2 Diabetes Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Type 2 Diabetes Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 107. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Digital Diabetes Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Digital Diabetes Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 128. North America Digital Diabetes Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. North America Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 130. North America Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 131. North America Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 132. North America Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 133. North America Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 134. North America Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 135. North America Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 136. North America Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 137. North America Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 138. North America Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 139. North America Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. North America Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. North America Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 142. Latin America Digital Diabetes Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Latin America Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 144. Latin America Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 145. Latin America Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 146. Latin America Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 147. Latin America Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 148. Latin America Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 149. Latin America Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 150. Latin America Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 151. Latin America Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 152. Latin America Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 153. Latin America Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. Latin America Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Latin America Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 156. Europe Digital Diabetes Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Europe Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. Europe Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 159. Europe Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 160. Europe Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 161. Europe Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 162. Europe Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 163. Europe Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 164. Europe Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 165. Europe Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 166. Europe Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 167. Europe Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. Europe Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. Europe Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 170. Middle East Digital Diabetes Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Middle East Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 172. Middle East Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 173. Middle East Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 174. Middle East Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 175. Middle East Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 176. Middle East Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 177. Middle East Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 178. Middle East Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 179. Middle East Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 180. Middle East Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 181. Middle East Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Middle East Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. Middle East Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 184. Africa Digital Diabetes Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Africa Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 186. Africa Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 187. Africa Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 188. Africa Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 189. Africa Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 190. Africa Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 191. Africa Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 192. Africa Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 193. Africa Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 194. Africa Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 195. Africa Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Africa Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. Africa Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 198. Global Digital Diabetes Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 199. ASEAN Digital Diabetes Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. ASEAN Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 201. ASEAN Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 202. ASEAN Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 203. ASEAN Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 204. ASEAN Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 205. ASEAN Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 206. ASEAN Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 207. ASEAN Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 208. ASEAN Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 209. ASEAN Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 210. ASEAN Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. ASEAN Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. ASEAN Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 213. GCC Digital Diabetes Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. GCC Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 215. GCC Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 216. GCC Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 217. GCC Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 218. GCC Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 219. GCC Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 220. GCC Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 221. GCC Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 222. GCC Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 223. GCC Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 224. GCC Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. GCC Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. GCC Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 227. European Union Digital Diabetes Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 228. European Union Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 229. European Union Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 230. European Union Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 231. European Union Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 232. European Union Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 233. European Union Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 234. European Union Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 235. European Union Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 236. European Union Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 237. European Union Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 238. European Union Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. European Union Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. European Union Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 241. BRICS Digital Diabetes Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. BRICS Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 243. BRICS Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 244. BRICS Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 245. BRICS Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 246. BRICS Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 247. BRICS Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 248. BRICS Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 249. BRICS Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 250. BRICS Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 251. BRICS Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 252. BRICS Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. BRICS Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. BRICS Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 255. G7 Digital Diabetes Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 256. G7 Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 257. G7 Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 258. G7 Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 259. G7 Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 260. G7 Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 261. G7 Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 262. G7 Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 263. G7 Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 264. G7 Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 265. G7 Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 266. G7 Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 267. G7 Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. G7 Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 269. NATO Digital Diabetes Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 270. NATO Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 271. NATO Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 272. NATO Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 273. NATO Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 274. NATO Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 275. NATO Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 276. NATO Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 277. NATO Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 278. NATO Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 279. NATO Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 280. NATO Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. NATO Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. NATO Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 283. Global Digital Diabetes Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 284. United States Digital Diabetes Management Market Size, 2017-2032 (USD Million)
TABLE 285. United States Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 286. United States Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 287. United States Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 288. United States Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 289. United States Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 290. United States Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 291. United States Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 292. United States Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 293. United States Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 294. United States Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 295. United States Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. United States Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. United States Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 298. Canada Digital Diabetes Management Market Size, 2017-2032 (USD Million)
TABLE 299. Canada Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 300. Canada Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 301. Canada Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 302. Canada Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 303. Canada Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 304. Canada Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 305. Canada Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 306. Canada Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 307. Canada Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 308. Canada Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 309. Canada Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 310. Canada Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 311. Canada Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 312. Mexico Digital Diabetes Management Market Size, 2017-2032 (USD Million)
TABLE 313. Mexico Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 314. Mexico Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 315. Mexico Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 316. Mexico Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 317. Mexico Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 318. Mexico Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 319. Mexico Digital Diabetes Management Market Size, by Telehealth Services, 2017-2032 (USD Million)
TABLE 320. Mexico Digital Diabetes Management Market Size, by Delivery Method, 2017-2032 (USD Million)
TABLE 321. Mexico Digital Diabetes Management Market Size, by Implantable Devices, 2017-2032 (USD Million)
TABLE 322. Mexico Digital Diabetes Management Market Size, by Wearable Devices, 2017-2032 (USD Million)
TABLE 323. Mexico Digital Diabetes Management Market Size, by End User, 2017-2032 (USD Million)
TABLE 324. Mexico Digital Diabetes Management Market Size, by Application, 2017-2032 (USD Million)
TABLE 325. Mexico Digital Diabetes Management Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 326. Brazil Digital Diabetes Management Market Size, 2017-2032 (USD Million)
TABLE 327. Brazil Digital Diabetes Management Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 328. Brazil Digital Diabetes Management Market Size, by Glucose Monitoring Devices, 2017-2032 (USD Million)
TABLE 329. Brazil Digital Diabetes Management Market Size, by Insulin Pumps, 2017-2032 (USD Million)
TABLE 330. Brazil Digital Diabetes Management Market Size, by Mobile Apps, 2017-2032 (USD Million)
TABLE 331. Brazil Digital Diabetes Management Market Size, by Software Solutions, 2017-2032 (USD Million)
TABLE 332. Brazil Digital Diabetes Management Market Size, by Clinical Decision Support Systems, 2017-2032 (USD Million)
TABLE 333. Brazil Digital Diabetes Management Market Size, by Telehealth Services, 20

Companies Mentioned

  • Abbott Laboratories
  • Afon Technology Ltd
  • AgaMatrix Inc
  • Ascensia Diabetes Care Holdings AG
  • B Braun Melsungen AG
  • Beta Bionics Inc
  • Biolinq Inc
  • DarioHealth Corp
  • Dexcom Inc
  • Diabeloop SA
  • Eli Lilly and Company
  • Embecta Corp
  • F Hoffmann La Roche Ltd
  • Glooko Inc
  • Insulet Corporation
  • LifeScan Inc
  • Medtronic plc
  • Medtrum Technologies Inc
  • MicroPort Scientific Corporation
  • Modular Medical Inc
  • One Drop
  • Senseonics Holdings Inc
  • Signos Inc
  • Tandem Diabetes Care Inc
  • Terumo Corporation
  • Virta Health Corp
  • Ypsomed Holding AG

Table Information

Report AttributeDetails
No. of Pages195
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 27.25 Billion
Forecasted Market Value ( USD ) by 2032 $ 79.86 Billion
Compound Annual Growth Rate19.7%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Artificial Intelligence in Diabetes Management Market - Global Forecast 2026-2032 - Product Image

Artificial Intelligence in Diabetes Management Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Digital Diabetes Management Market Report by Product Type, Device Type, and Region 2026-2034 - Product Image

Digital Diabetes Management Market Report by Product Type, Device Type, and Region 2026-2034

  • Report
  • 148 Pages
  • Global
From
Digital Diabetes Management Market Report 2026 - Product Image

Digital Diabetes Management Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Blood Glucose Monitor Market by Product Type (Self Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Global Forecast to 2030 - Product Image

Blood Glucose Monitor Market by Product Type (Self Blood Glucose Monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site (Fingertip, Upper Arm), End User (Self/Homecare) - Global Forecast to 2030

  • Report
  • 302 Pages
  • Global
From
Software as a Medical Device (SaMD) for Diabetes Management - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Software as a Medical Device (SaMD) for Diabetes Management - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 150 Pages
  • Global
From

About the Market

The Digital Diabetes Management market is a subset of the larger Diabetes Devices market. It includes products and services that enable people with diabetes to monitor and manage their condition digitally. These products and services include connected glucose meters, insulin pumps, continuous glucose monitors, and mobile applications. Digital Diabetes Management solutions provide users with real-time data on their glucose levels, allowing them to make informed decisions about their diabetes management. Additionally, these solutions can be used to track diet, exercise, and other lifestyle factors that can affect diabetes. Some companies in the Digital Diabetes Management market include Dexcom, Insulet, Medtronic, Abbott, and Glooko. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.